MAPT and Alzheimer disease: Given that p-tau181 is relatively specific to AD pathology,12 it is also crucial to investigate whether other p-tau species, such as p-tau217 and p-tau231, which have higher specificity for AD, are also elevated in patients with NIID with p-tau181.